BECTON DICKINSON and CO

BD names Bridget Bagnato as Worldwide President of Peripheral Intervention, boosting innovation, operational excellence, and global access to vascular and oncologic therapies.

BD’s 2026 AGM wins unanimous approval, boosting governance and opening convertible notes plus private placement to fuel growth, innovation, and shareholder value.

Explore Becton, Dickinson’s premium valuation, conservative dividend strategy, and evidence‑based medical‑device portfolio—why the stock may appeal to stability‑seekers.